Urocid-N 100 ml oral solution: Each 5 ml solution contains Potassium Citrate BP 1500 mg and Citric Acid Monohydrate BP 250 mg.
Urocid-N 200 ml oral solution: Each 5 ml solution contains Potassium Citrate BP 1500 mg and Citric Acid Monohydrate BP 250 mg.
Potassium Citrate and Citric Acid oral solution is a stable and pleasant-tasting oral systemic alkalinizer. Potassium Citrate is absorbed and metabolized to Potassium Bicarbonate, thus acting as a systemic alkalinizer. This product alkalinizes the urine without producing a systemic alkalosis in recommended doses. It is highly palatable, pleasant tasting and tolerable, even when administered for long periods. Potassium Citrate does not neutralize the gastric juice or disturb digestion.
Route of administration: Oral.
Indication:
Age.
Dosage:
Remarks.
Adults and children (over 6 years).
10 ml 3 times daily.
diluted with 1 glass of water.
Children (1 - 6 years):
5 ml 3 times daily.
diluted with ½ glass of water.
Adults:
10-15 ml 4 times daily; or as directed by the physician.
diluted with 1 glass of water.
Pediatric.
5-10 ml 4 times daily; or as directed by the physician.
diluted with ½ glass of water.
With medicine: Concurrent administration of potassium-containing medication, potassium-sparing diuretics, angiotensin-converting enzyme (ACE) inhibitors or cardiac glycosides may lead to toxicity.
With food & Others: No adequate data found.
Overdose:
The administration of oral Potassium salts to persons with normal excretory mechanisms for potassium rarely causes serious hyperkalemia. However, if excretory mechanisms are impaired, hyperkalemia can result. Hyperkalemia, when detected, must be treated immediately because lethal levels can be reached in a few hours. If hyperkalemia occurs, treatment measures will include the followings: (1) Elimination of foods or medications containing potassium. (2) The intravenous administration of 300 to 500 ml/hr of dextrose solution (10 to 25%), containing 10 units of insulin/20 gm dextrose. (3) The use of exchange resins, hemodialysis or peritoneal dialysis.
No information is available regarding the use of this drug during pregnancy and lactation.
See the dose and administration.
The solution should be used with caution in patients with low urinary output. It should be diluted adequately with water to minimize the possibility of gastrointestinal injury associated with the oral ingestion of concentrated Potassium salt preparations; and preferably, to take each dose after meals. Large doses may cause hyperkalemia and alkalosis, especially in the presence of renal disease.
Store below 30° C temperature. Keep in a cool and dry place, away from light. Keep out of the reach of children.